1. IL22RA1/JAK/STAT Signaling Acts As a Cancer Target Through Pan-Cancer Analysis
   Shuai Zhang et al, 2022, Frontiers in Immunology CrossRef
2. Mesenchymal Stem Cells Engineered by Nonviral Vectors: A Powerful Tool in Cancer Gene Therapy
   Yuan Ding et al, 2021, Pharmaceutics CrossRef
3. Time-Dependent Internalization of S100B by Mesenchymal Stem Cells via the Pathways of Clathrin- and Lipid Raft-Mediated Endocytosis
   Ying Zhang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
4. Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies
   Noha Attia et al, 2021, Cells CrossRef
5. HIF-1α promotes the migration and invasion of cancer-associated fibroblasts by miR-210
   Ying Yang et al, 2021, Aging and disease CrossRef
6. Th22 Cells/IL-22 Serves as a Protumor Regulator to Drive Poor Prognosis through the JAK-STAT3/MAPK/AKT Signaling Pathway in Non-Small-Cell Lung Cancer
   Yinan Yao et al, 2022, Journal of Immunology Research CrossRef
7. Comprehensive analysis of competitive endogenous RNA associated with immune infiltration in lung adenocarcinoma
   Wenjie Chen et al, 2021, Scientific Reports CrossRef